In short: Hip replacement is a well-established solution for advanced hip osteoarthritis. For many patients, conservative care meaningfully reduces pain first. Mesenchymal stem cell therapy is an evidence-informed but still developing option for selected patients with mild-to-moderate disease who want to postpone arthroplasty. For severe structural damage, replacement remains the more reliable choice.
Non-surgical options to try first
- Education and activity modification: joint protection, pacing and lifestyle adaptation.
- Exercise and physical therapy: strengthening of hip abductors and core, gait training and flexibility work to reduce load and improve mechanics.
- Weight management: losing weight reduces joint stress and correlates with symptom improvement.
- Analgesics and anti-inflammatories: acetaminophen and NSAIDs, topical or oral, used judiciously.
- Intra-articular corticosteroid injections: short-term relief for flares, and useful for diagnostic clarification.
- Supports and orthoses: cane use, shoe modifications and targeted bracing where indicated.
What stem cell therapy is, and how it may help
Stem cell therapy for hip pain typically uses mesenchymal stem cells (MSCs). At Stem Cells Colombia these are derived from umbilical cord Wharton’s jelly. The cells act primarily through paracrine mechanisms: they secrete anti-inflammatory cytokines, growth factors and extracellular vesicles that modulate the joint environment, reduce chronic inflammation and support tissue repair processes. They are delivered by image-guided intra-articular injection into the hip, or targeted to periarticular structures.
Potential benefits reported in the literature
- Pain reduction: clinical studies and case series report clinically meaningful decreases in pain scores for some patients with mild-to-moderate hip osteoarthritis.
- Functional improvement: many treated patients report better mobility, walking tolerance and activity participation.
- Possible delay of surgery: for selected patients, symptom relief can defer the need for arthroplasty by months to years — particularly relevant for younger patients.
- Safety profile in regulated settings: with proper sterility, patient screening and standardised protocols, reported short- to mid-term adverse events are typically mild and transient, such as soreness or temporary swelling.
- Adjunct to multimodal care: the approach works best combined with rehabilitation, weight management and activity modification.
Evidence summary and realistic expectations
Research on MSCs for hip osteoarthritis is promising and still evolving. Systematic reviews suggest potential benefits in pain and function for selected patients, while noting that study sizes are small, protocols vary widely between centres and follow-up is often short. Stem cell therapy should therefore be understood as an evidence-informed but still developing option — appropriate for patients who have exhausted optimised conservative therapy and who understand that outcomes vary and results cannot be guaranteed.
When hip replacement remains the right choice
Hip arthroplasty is generally indicated when:
- Severe pain substantially limits daily activities or sleep despite optimised non-surgical care.
- Imaging shows advanced joint destruction, severe joint-space loss, deformity or structural instability.
Patient selection at Stem Cells Colombia
- Comprehensive evaluation: we confirm that guideline-based conservative care has been tried, review imaging and medical history, and assess goals and expectations.
- Individualised recommendation: if you are a candidate — typically mild-to-moderate osteoarthritis, suitable health status, realistic goals — we discuss the protocol, likely outcomes, costs and follow-up.
- Integrated care: stem cell therapy is offered as part of a multimodal plan including structured rehabilitation and outcome tracking.
See our hip regeneration treatment or read about the cells we use.
Frequently asked questions
Can stem cell therapy replace hip surgery?
No. It may relieve symptoms and postpone surgery in selected patients with mild-to-moderate disease, but it does not reverse advanced structural damage. Where the joint is severely destroyed, replacement remains the more reliable option.
How soon would I notice a change?
Patients who respond typically report gradual change over weeks to a few months rather than immediately. Some patients notice little difference. Structured follow-up is how we assess your actual response.
Is it painful, and how long is the recovery?
The injection is image-guided and performed under local anaesthesia with mild sedation. Reported side effects are usually mild and short-lived, such as soreness or temporary swelling. Most international patients stay in Medellín for two to five days.
Which cells do you use?
Passage 3 mesenchymal stem cells from umbilical cord Wharton’s jelly, donated after healthy scheduled births with maternal consent and screening.
Next steps
If you are asking whether you have to have hip surgery, start with a structured non-surgical programme. For selected patients who meet clear criteria and want to explore regenerative options, mesenchymal stem cell therapy may be a useful adjunct. The decision should be individualised and based on imaging, symptoms, prior treatment response and informed patient preference.
References
- American Academy of Orthopaedic Surgeons. (2019). Management of osteoarthritis of the hip. aaos.org
- National Institute for Health and Care Excellence. (2014). Osteoarthritis: care and management (CG177). nice.org.uk
- Mardones, R., Jofré, C. M., et al. (2017). Mesenchymal stem cell therapy in the treatment of hip osteoarthritis. Journal of Hip Preservation Surgery, 4(2), 159–163. academic.oup.com
- Management of hip osteoarthritis: harnessing the potential of mesenchymal stem cells — a systematic review. (2024). PubMed Central
This article is for general information and does not constitute medical advice. Stem cell therapy does not guarantee results and is not a cure. Eligibility requires review of your medical history and imaging by a physician. Individual results vary.